Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enovix Corporation (ENVX) SEC filings page on Stock Titan provides access to the company’s official U.S. regulatory documents, along with AI-powered summaries to help interpret complex disclosures. As a Nasdaq-listed battery technology company focused on advanced lithium-ion cells and 100% active silicon-anode architectures, Enovix uses its SEC reports to describe financial performance, capital structure, risk factors and material events.
Through this page, you can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Enovix’s business model, battery technology, manufacturing footprint in regions such as Malaysia and South Korea, and markets including smartphones, smart eyewear, IoT, industrial and defense applications. Our AI tools highlight key sections, such as revenue trends, operating expenses, liquidity, and the Risk Factors and MD&A discussions referenced in the company’s press releases.
You can also follow current reports on Form 8-K, where Enovix has disclosed items such as quarterly financial results, a warrant dividend distribution, authorization of a share repurchase plan, and the issuance of 4.75% Convertible Senior Notes due 2030 with related capped call transactions. These filings explain terms of the notes, conversion conditions, redemption provisions and the intended use of proceeds, including potential acquisitions in the battery ecosystem.
In addition, this page surfaces registration statements, prospectus supplements and related exhibits that describe the warrant program (ENVXW), share issuance mechanics and legal opinions, as well as any future Form 4 insider transaction reports when available. AI-generated overviews help clarify technical language, summarize covenant and event-of-default provisions, and point out changes in capital structure or share count. Together, these tools allow investors to navigate Enovix’s regulatory history more efficiently while still relying on the underlying SEC documents as the authoritative source.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a routine tax-withholding share disposition related to equity compensation. On this Form 4, 2,221 shares of common stock were withheld at $4.88 per share to cover tax obligations from the vesting of restricted stock units.
After this withholding, Chakravarthy directly holds 454,982 shares of Enovix common stock. This total includes 256,400 shares issuable upon vesting and settlement of RSUs, 10,393 vested performance RSUs scheduled for release in March 2027, and 58,500 additional performance RSUs scheduled for release in April 2027 and April 2028.
Enovix Corp ownership filing shows The Vanguard Group reports 0 shares and 0% beneficial ownership of Common Stock in an Amendment No. 2 to a Schedule 13G/A, reflecting internal disaggregation after an internal realignment described in the filing.
The filing explains certain Vanguard subsidiaries will report separately in reliance on SEC Release No. 34-39538 (January 12, 1998). Signature block lists Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Enovix Corp Chief Accounting Officer Kristina Truong reported routine share transfers and tax-related dispositions. On March 16, 2026 she made a bona fide gift of 6,000 shares of common stock, giving 3,000 shares to each of her two children, with no purchase or sale involved. On March 13, 2026, 970 shares were withheld at $4.94 per share to satisfy tax obligations tied to vesting restricted stock units. After these transactions she directly holds 218,356 common shares. Her holdings also include rights to additional shares through 134,843 RSUs, 2,489 vested PRSUs scheduled for release in March 2027, and 35,278 PRSUs expected to be released in tranches in April 2027 and April 2028.
Enovix Corp Chief Accounting Officer Kristina Truong reported a routine tax-withholding share disposition related to equity compensation. On March 10, 2026, 241 shares of common stock were withheld at $4.94 per share to satisfy tax obligations from vesting restricted stock units (RSUs). This was not an open-market sale. After the withholding, Truong directly holds 225,326 shares of common stock, which includes 136,759 shares issuable upon RSU vesting and settlement and performance RSUs scheduled for release between March 2027 and April 2028.
Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition. On this Form 4, 4,109 shares of common stock were withheld at $4.85 per share to cover tax obligations tied to vesting restricted stock units. This was not an open-market sale. After the withholding, he holds 2,434,114 common shares directly. Footnotes also show 1,438,838 shares underlying unvested RSUs, 47,775 vested PRSUs scheduled for release in March 2027, and 259,611 additional PRSUs scheduled for release in April 2027 and April 2028.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a small share disposition tied to tax withholding. On the vesting of restricted stock units, 894 shares of common stock were withheld at $4.85 per share to cover tax obligations, leaving her with 457,203 shares held directly.
Her position includes 260,594 additional shares issuable upon future RSU vesting, 10,393 vested performance RSUs scheduled for release in March 2027, and 58,500 performance RSUs expected to be released in two stages in April 2027 and April 2028.
Enovix Corp Chief Accounting Officer Kristina Truong reported acquiring common stock through the vesting of performance restricted stock units (PRSUs) after performance criteria were achieved on February 18, 2026. Awards covering 24,116 PRSUs and 11,162 PRSUs vested at a price of $0.00 per share.
The 24,116 vested PRSUs will be released in two equal installments on April 1, 2027 and April 1, 2028, and the 11,162 vested PRSUs will be released in two equal installments on April 8, 2027 and April 8, 2028. Each PRSU represents a contingent right to receive one share of Enovix common stock upon settlement.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported an acquisition of common stock through the vesting of performance-based equity awards. On February 18, 2026, 36,174 performance restricted stock units (PRSUs) vested upon achievement of performance criteria, with 50% scheduled for release on April 1, 2027 and the remaining 50% on April 1, 2028.
On the same date, an additional 22,326 PRSUs vested, with 50% to be released on April 8, 2027 and 50% on April 8, 2028. Each PRSU represents a contingent right to receive one share of Enovix common stock upon settlement. Following these transactions, Chakravarthy directly owned 458,097 shares, including 262,360 shares issuable upon vesting and settlement of RSUs and previously vested PRSUs.
Talluri Rajendra K reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp President and CEO Rajendra K. Talluri reported awards of common stock tied to performance-based restricted stock units. On February 18, 2026, 168,813 PRSUs vested after meeting performance criteria; 50% will be released on April 1, 2027 and 50% on April 1, 2028.
On the same date, 90,798 additional PRSUs vested, with 50% scheduled for release on April 8, 2027 and the remainder on April 8, 2028. Reported direct holdings include shares plus 1,446,958 shares issuable upon vesting and settlement of RSUs and vested PRSUs, including 47,775 PRSUs to be released on March 2, 2027.
Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-withholding share disposition. On March 2, 2026, 1,260 shares of common stock were withheld at $5.45 per share to satisfy tax obligations tied to vested performance restricted stock units.
After this transaction, she directly owns 190,289 shares, including 137,235 shares issuable upon vesting and settlement of restricted stock units and 2,489 vested performance RSUs scheduled for release on March 2, 2027.